September 2, 2015

he campaign is being undertaken in partnership with the American Chronic Pain Association, the Pain Community, the U.S. Pain Foundation and the American Academy of Pain Management.

September 2, 2015

The collaboration will see them working on a BACE inhibitor program to treat Alzheimer’s disease and developing Amgen’s migraine drugs.

September 2, 2015

Sandoz on Wednesday introduced rivastigmine transdermal system, a generic version of Exelon Patch1, in the United States.

September 1, 2015

PrescribeMedicare is meant to serve as a tool for patients in 2016 when open enrollment for plan choices begins.

September 1, 2015

The company said the patch is a potential solution for the 73% of migraine sufferers who experience nausea with their migraines. 

August 31, 2015

With Naurex, Allergan potentially expands its development of mental health treatments, as the acquired company’s focus is on developing therapies for brain and nervous system disorders like depression. 

August 31, 2015

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

August 28, 2015

Alvogen on Wednesday announced that it will acquire a portfolio of four pharmaceutical products in the United States from Pfizer.

August 28, 2015

Amgen announced Friday that the Food and Drug Administration had approved its new cholesterol treatment Repatha (evolocumab) injection.

August 28, 2015

The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.

August 28, 2015
The transaction, whose details won’t be disclosed, is expected to be completed in the third quarter of 2015.
August 26, 2015

The National Association of Chain Drug Stores has announced the winners of its Total Store Expo Product Showcase. 

August 25, 2015

The drug can be used in children 1 year of age and older with ITP who have not had a sufficient response to a splenectomy, immunoglobulins or corticosteroids.

August 25, 2015
According to GlobalData’s report, the market is set to grow from $29.4 billion in 2014 to $47.9 billion by 2020, which represents a compound annual growth rate of 8.5%.
August 23, 2015

IMS Health’s Doug Long gave an overview of the present state of the U.S. pharmaceutical market and where it might be headed in the coming months and years at NACDS Total Store Expo on Sunday.

August 22, 2015

Starting Oct. 1, under the revised rules, TRICARE beneficiaries who regularly take certain brand-name medication will have to get their prescriptions filled at a military treatment facility or through a mail-in program.

August 21, 2015

Ateb provides technology solutions to help independent and chain pharmacies improve patient adherence through education, pharmacy interventions and patient reminders. Drug Store News recently spoke with president and CEO Frank Sheppard.

August 21, 2015

Galderma Laboratories has announced that Epiduo Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5%, is available in retail pharmacies nationwide and in Puerto Rico. 

August 20, 2015

Tylenol has retaken the OTC pain relief aisle with a vengeance. The brand is close to reclaiming the top spot among internal analgesic tablets behind Aleve and Advil and is growing at a 10% rate on a dollar base of more than $250 million. 

August 20, 2015

The news of the acquisition comes a day after Sprout received FDA approval for its Addyi — dubbed “female Viagra” by many in the lead-up to its approval.

August 19, 2015

Levy will provide key insights on the changing healthcare industry to advance the board's mission of helping consumers make more informed healthcare decisions.

August 19, 2015

The Food and Drug Administration handed down its anticipated approval of Sprout Pharmaceuticals’ Addyi, a treatment for women with generalized hypoactive sexual desire disorder. 

August 14, 2015
Pfizer on Friday announced that it would be selling four of its Canadian pharmaceutical products to alleviate concerns from Canada’s Competition Bureau and pave the way for its acquisition of Hospira. 
August 14, 2015

Nearly 13% of U.S. Hispanic adults are already diagnosed with diabetes, one of the highest prevalence rates among ethnic groups in the country.